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Abstract
Background: This study aimed the feasibility to assess longitudinal changes in biomarkers of cartilage turnover and
to determine their relationship with patient-rated outcomes over 2 years in volleyball athletes.
Methods: Thirty-seven athletes were studied: 18 adolescents (age 15.9 ± 0.64 years) in a 2-year intensive volleyball
training program and 19 adult recreational volleyball players (age 46.5 ± 4.9 years). Blood and serum samples were
taken at baseline (BL) and 2-year follow-up (FU). Subjects completed the International Knee Documentation
Committee (IKDC) Subjective Knee Form and the Short-Form 36 (SF-36) at BL.
Results: Thirteen adolescents (72%) had open growth plates at BL (BL open adolescents), the rest had closed
growth plates at BL (BL closed adolescents), and all but one adolescent had closed growth plates at FU as assessed
by MRI. BL open and closed adolescents had greater levels of the cartilage degradation-based biomarkers 45 mer
collagenase peptide of type II collagen (C2C-HUSA) and C-telopeptide of type II collagen (CTX-II) than adults. BL
open adolescents showed decreases in C2CHUSA, collagen synthesis marker C-propeptide of type II procollagen
(CPII), and CTXII, and adults showed increases in cartilage intermediate layer protein 2 (CILP-2) and C2C-HUSA. In
adolescents, IKDC scores were correlated with CPII changes. In adults, SF-36 Physical Component Scores were
correlated with cartilage oligomeric matrix protein (COMP) changes.
Conclusion: Significant differences in biomarker levels over time show the feasibility to assess their changes.
Greater levels of C2C-HUSA and CTX-II in adolescents than in adults may reflect increased cartilage turnover in
response to higher joint loading. CPII and COMP may be more reflective of subjective patient outcomes. These
biomarkers may thus be useful in assessing mechanical loading-induced cartilage changes, their associated
symptoms, and Osteoarthritis risk in athletes.
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Background
Osteoarthritis (OA) is the most common type of arthritis
and causes more functional disability than any other dis-
ease (Felson 2014). Primary knee OA is frequently asso-
ciated with mechanical overloading of joints (Kujala et
al. 1994) and is characterized by degradation of the
whole joint including cartilage, subchondral bone and
surrounding soft tissue (Felson et al. 2000). Previous
findings have suggested that high-impact physical activ-
ity (Kujala et al. 1994, Kujala et al. 1995, Buckwalter and
Lane 1997, Amoako and Pujalte 2014) and/or prior knee
injury (Muthuri et al. 2011, Richmond et al. 2013) in-
crease the risk of developing primary OA. However, it is
unclear how frequency and intensity of exercise affect
human articular cartilage degradation (Hallett and
Andrish 1994, Saxon et al. 1999).
Biomarkers of cartilage turnover may reflect structural
cartilage changes and thus may identify patients at risk
of early onset of OA (Rousseau and Delmas 2007). Previ-
ous studies have found that biomarkers of cartilage turn-
over are altered in athletes after a session of running
(Kersting et al. 2005, Niehoff et al. 2011), as well as in
varsity collegiate soccer, crew, and swimming athletes
after a sports season (O’Kane et al. 2006, Hoch et al.
2012, Mateer et al. 2015). Although past studies have
investigated longitudinal changes in biomarkers of
cartilage turnover in athletes of a high-impact sport, e.g.
soccer, over a sports season (O’Kane et al. 2006, Hoch
et al. 2012, Mateer et al. 2015), more long-term
changes in such biomarkers in an athletic population
remain unclear. Some of these biomarkers may also re-
main elevated from 1 to 7 years post-injury in athletes
who have suffered a knee injury (Ahlen et al. 2015,
Kumahashi et al. 2015, Struglics et al. 2015). Addition-
ally, it is important to understand how subjective clin-
ical outcomes are related to changes in biomarkers of
cartilage turnover in athletes, which may help deter-
mine which biomarkers are most reflective of such pa-
tients’ self-reported status.
Long-term changes in biomarkers of cartilage turn-
over in athletes of a high-impact sport are currently
unknown. Moreover, the effects of exercise on cartil-
age wear in adolescent and adult athletes may be dif-
ferent due to the different developmental stages of
these populations. It was previously found that femor-
otibial cartilage thickness increases in adolescent vol-
leyball players and decreases in adult volleyball
players over 2 years (Eckstein et al. 2014). Another
study found that 64% of adolescent soccer players dis-
play knee abnormalities by Magnetic Resonance Im-
aging (MRI), particularly bone marrow edema (Soder
et al. 2011). Thus, investigating differences between
biomarkers of cartilage turnover in adolescent and
adult athletes could provide insights into how these
biomarkers reflect different cartilage changes and ad-
aptations to exercise in these two populations.
The primary goals of this study were to compare
values of and changes in biomarkers of cartilage turn-
over over 2 years between adolescent and adult vol-
leyball players in order to investigate the roles of
growth plate development and volleyball activity on
biomarkers of cartilage turnover. The secondary goals
were to assess the correlations between baseline (BL)
patient-rated outcome measures (PROMs) and longi-
tudinal changes in these biomarkers. Through these
goals, we aimed to investigate the roles of volleyball
activity and growth plate development on biomarkers
of cartilage turnover, which could reflect both
exercise-induced and pre-osteoarthritic knee degrad-
ation, and also to assess which biomarkers might be
clinically relevant. Our hypotheses were that 1) adult
volleyball athletes would have higher levels and in-
creases in biomarkers of cartilage degradation than
adolescent volleyball athletes, due to the former’s
more advanced age and greater lifetime cumulative
joint loading; 2) adolescent volleyball athletes would
have higher levels and increases in biomarkers of car-
tilage synthesis due to their continuing growth; and




This was a prospective, longitudinal cohort study (Level
III) which received approval from an Institutional Review
Board. A convenience sample of 40 volleyball athletes (20
adolescents and 20 adults) was initially recruited, and all
provided written informed consent for participation. For
adolescents, inclusion criteria were age less than or equal
to 17 years, current participation in the 2-year volleyball
training program at Olympiastützpunkt Berlin, and prior
volleyball participation in a club for at least 3 years. For
adults, inclusion criteria were age greater than 40 years (in
order to have an adult cohort that was significantly older
than the adolescent cohort and thus would have likely ex-
perienced greater joint degradation over time), past par-
ticipation in the volleyball training program at
Olympiastützpunkt Berlin, but with ongoing exclusive and
continued volleyball participation for at least 2 h a day,
twice a week. Exclusion criteria for both groups were prior
knee injury requiring surgery less than 1 year prior to the
BL evaluation. The volleyball training program at
Olympiastützpunkt Berlin consisted of 2-h training ses-
sions twice daily, 6 days a week, for 2 years.
Two adolescent males with Osgood-Schlatter disease
were excluded due to its confounding effects on bio-
markers of cartilage turnover and skeletal metabolism
(Frantz et al. 2010). One adult male was excluded due to
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insufficient serum and urine sample volumes. Thus, the
final cohort consisted of 37 volleyball athletes, with 18
adolescents and 19 adults (Table 1). Biomarkers of cartil-
age turnover were evaluated in all subjects at BL and at
2-year follow-up (FU).
At BL, all subjects were evaluated by a self-reported
questionnaire for knee pathology and prior knee injuries
that required surgical intervention. One female adoles-
cent had an ACL tear that had been surgically repaired.
Two adolescent males and two adolescent females had
patellar pain syndrome. Eight adults had prior knee sur-
gery. Among the adult males, one had a lateral menisc-
ectomy, one had lateral and medial meniscectomies and
articular cartilage debridement, one had other knee sur-
gery, and one had cartilage debridement and a meniscus
surgery. Among the adult females, one had a nerve tran-
section and knee cartilage debridement, one had knee
arthroscopy, one had meniscus surgery, and one had a
medial meniscectomy. One male adult reported pain
below the patella, and two adult females had knee pain.
No subjects experienced injuries between BL and 2-year
FU. Biomarker levels and patient-rated outcomes were
compared between adults with and without prior knee
injury to determine how this variable influenced results.
Sample collection
All blood samples were obtained following an overnight
fast and urine samples were collected on the second
morning void. Serum and urine samples were collected
at both BL and at FU after subjects had received MRI
scans and thus had been inactive and lying down for
45 min before being seated for approximately 10 min.
Serum samples were obtained from 29 subjects at BL
(11 adolescents and 18 adults) and 36 subjects at FU (17
adolescents and 19 adults). Serum samples were insuffi-
cient due to a limited amount of blood that had been
taken in seven adolescent females and one adult female
at BL and in one adolescent male at FU. One adolescent
male was missing a urine sample at FU. However, these
subjects were included in the analysis as they had ad-
equate samples for at least one time point.
Patient-rated outcomes
To assess subjective clinical status, all subjects com-
pleted the International Knee Documentation Com-
mittee (IKDC) Subjective Knee Form and the Short-
Form 36 (SF-36) at BL. The IKDC is a validated
patient-rated outcome measure that evaluates symp-
toms, function, and sports activity in patients with
various knee problems (Irrgang et al. 2001). The SF-36
is a validated metric for general health outcomes
(Patel et al. 2007), and both the Physical Component
Score (PCS) and Mental Component Score (MCS)
were assessed. For each outcomes measure, scores
range from 0 to 100, with a lower score indicating
greater disability.
Magnetic resonance imaging (MRI)
Since the adolescents’ growth status likely affected the
levels of biomarkers assessed, the status of their femoral
and tibial growth plates was assessed at BL and FU with
magnetic resonance imaging (MRI). MRI was performed
in a 1.5 T Avanto scanner (Siemens Medical Systems, Er-
langen, Germany) using a dedicated 8-channel knee coil.
The take-off leg was imaged in all participants in supine
position with the leg in full extension. A 2D coronal
proton-density (PD) weighted turbo spin-echo MR se-
quence with fat suppression (0.4167×0.4167 mm in-
plane resolution, 3 mm slice thickness, 3.6 mm slice spa-
cing, 29 ms echo time, 3520 ms repetition time, 150° flip
angle) as well as a 3D axial T2-weighted Multi-Echo
Data Image Combination (MEDIC) sequence
(0.167×0.167 mm in-plane resolution, 1.2 mm slice
thickness, 21 ms echo time, 38 ms repetition time, 8° flip
angle) were used for imaging at both BL and FU. All im-
ages were assessed on a picture archiving communica-
tions system (PACS) by a radiologist with 12 years of
experience in musculoskeletal imaging. The radiologist
was blinded to the clinical information of each subject
and to the time point of the MRI.
Biomarker analyses
Serum and urine samples were immediately stored at
−70 °C until testing. After being frozen on dry ice, they
were transported for assay to AnaMar AB (Lund,
Sweden) and IBEX Pharmaceuticals (Montreal, Quebec,
Canada).
The serum cartilage molecular biomarkers studied
were the collagen degradation markers cartilage oligo-
meric matrix protein (COMP), cartilage intermediate
layer protein 2 (CILP-2), and serum type II collagen
cleavage neoepitope (sC2C), as well as the collagen syn-
thesis marker C-propeptide of type II procollagen (CPII).
COMP is expressed as U/L, and CILP-2, sC2C, and CPII
are expressed as ng/mL.
Table 1 Subject Demographics
Adolescents Adults P-value
Age [years] a 15.9 ± 0.64 46.5 ± 4.9 –
Weight [kg] a 76 ± 10.3 82.3 ± 16.2 0.047*
Height [cm] a 188.3 ± 7.8 183.2 ± 8.9 0.081
BMI [kg/m2] a 21.4 ± 1.8 24.3 ± 2.9 0.001*
Females b 10 (56) 10 (52) >0.999
Prior knee injury b 1 (5) 8 (42) 0.0188*
* Statistically significant difference (P < 0.05)
a Values expressed as mean ± standard deviation
b Values expressed as N (% of age group)
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The urine cartilage molecular biomarkers studied were
the collagen degradation markers 45-mer collagenase-
generated peptide of human type II collagen (C2C-
HUSA) and CTX-II, which are expressed as ng/mmol of
creatinine. At IBEX, all the samples were tested in dupli-
cate for all assays (C2C, CPII, C2C-HUSA and CTX-II
and urine creatinine). At AnaMar AB, all the samples
were tested in duplicate for COMP and CILP-2. All
study subjects were randomly assigned to the assay
plates regardless of which group they belonged to. Both
time points for each subject were always assayed on the
same plate.
Serum collagen degradation biomarkers
COMP was measured using a sandwich enzyme-linked
immunosorbent assay (ELISA) (AnaMar AB) and the
cartilage collagen degradation biomarker C2C (collage-
nase generated carboxy-terminal neoepitope of type II
collagen) using a competitive inhibition ELISA (IBEX).
CILP-2 was assayed using an in-house research competi-
tive ELISA (AnaMar AB).
Serum collagen synthesis biomarkers
CPII (type II procollagen carboxy-propeptide) was
assayed using a competitive inhibition ELISA (IBEX).
Urine type II collagen degradation biomarkers
Two biomarkers of degradation were measured in urine
samples: CTX-II (C-telopeptide of type II collagen) using
a competitive assay (CartiLaps; IDS) and C2C-HUSA
(collagenase-generated peptides of human type II colla-
gen) using a sandwich assay (IBEX) (Cibere et al. 2009).
Creatinine was measured at IBEX using an enzymatic
colorimetric kit (QuantiChrom™; BioAssay Systems,
Hayward, CA, USA).
Biomarker assays
The assay details, reproducibility (intra and inter assay
variation) and accuracy of all these assays (recovery of
added analyte) are described in detail on the websites of
the manufacturers (interassay variability: 2–3%, intraas-
say variability: 2–4%, recovery: 93–116%) with the ex-
ception of the competitive CILP-2 assay which is as
follows: Microtitre plates (Costar high binding 9018)
were coated with a 61 amino acid long synthetic poly-
peptide from the CILP2 domain 1 (V551-D611 (UniProt
Q8IUL8) Schafer-N, Copenhagen, Denmark). Plates were
incubated at room temperature overnight. Plates were
washed with PBS-Tween (PBS-T, Medicago) four times
and incubated with block solution (1% Probumin from
Millipore in PBS-T) for 2–3 h. Standard (range 100 ng/
ml-0.14 ng/ml) and athlete serum samples were diluted
1:10 in conjugate buffer (Medicago 25-0142+ 0.1 mg/ml
goat IgG from Sigma) and pre-incubated with HRP-
coupled anti-CILP-2 antibody (polyclonal affinity-
purified goat antibody (Capra Science, Sweden) against
the coating CILP-2 peptide) on non-binding plates (U96
PP 0.5 ml, Natural, Thermo Scientific) for 1 h. The
blocked plates were washed with PBS-T four times and
the pre-incubated sample was transferred to the freshly
washed plates followed by further incubation at room
temperature for 2 h. After washing with PBS-T (6 times)
TMB substrate (Medicago) was added and the signal
allowed developing for 20 min protected from light. The
reaction was stopped by the addition of 0.5 M H2SO4
before reading the plates at 450 nm. Samples were ana-
lysed in duplicate (patient samples from BL and FU were
run on the same plate). The CILP-2 assay standard, a
16 kDa protein (His6tagged aa C206-P246 merged with
V551-D611) was produced in E. coli and IMAC/Ni2+
column purified. Standard curve was produced by spik-
ing standard protein to non-detecting CILP-2 serum.
The CILP-2 competitive assay had an intra assay vari-
ation of 11.1% and the inter assay variations for high
control was 20.7% and for low control 22.2%. All ana-
lyses were carried out without any prior knowledge of
the individual samples.
Statistical analysis
Quantitative variables are expressed as means and
95% confidence intervals unless stated otherwise. Data
were assessed for normality using the Shapiro-Wilk
test. Demographic variables and patient-rated out-
come scores were normally distributed, whereas bio-
marker data were not. Adolescents were stratified by
BL growth plate status (open or closed) for biomarker
comparisons. Differences in BL and FU biomarker
levels between the three groups (BL open adolescents,
BL closed adolescents, and adults) were assessed with
Kruskal Wallis tests, with pairwise post-hoc analyses
when significant adjusted for multiple testing. Differ-
ences in biomarker levels between adults with and
without prior knee injuries were assessed with Mann
Whitney U tests. As there was only one adolescent
with prior knee injury, no comparison in biomarkers
was made between adolescents with and without prior
knee injury. Differences in demographic variables and
patient-rated outcomes were assessed with Student’s
t-tests. Longitudinal changes in biomarkers were
assessed with Wilcoxon Signed Rank tests. Correla-
tions between patient-rated outcomes and longitudinal
biomarker changes were assessed with Spearman’s
Rank Correlations. An r-value of 0.1 to 0.39 was con-
sidered a weak correlation, an r-value of 0.4 to 0.6
was considered a moderate correlation, and an r-value
of 0.61 to 1.0 was considered a strong correlation. A
one-way ANOVA was used to compare IKDC and
SF-36 scores between BL closed adolescents, BL open
Boeth et al. Journal of Experimental Orthopaedics  (2017) 4:7 Page 4 of 11
adolescents, and adults. All statistical tests were con-
ducted using SPSS Statistics 18 (IBM SPSS Statistics,
USA) with a significance level of 0.05.
Results
Patient-rated outcomes
At BL, adults had a mean IKDC score of 94.3 (range,
75.8 to 100.0) and a mean SF-36 PCS of 53.4 (range,
47.5 to 56.9). Adolescents had a mean IKDC score
of 93.9 (range, 70.1 to 100.0) and a mean SF-36 PCS
of 55.5 (range, 36.6 to 65.9). There were no signifi-
cant differences found in IKDC score (p = 0.885) or
SF-36 PCS (p = 0.193) between age groups. Adults
with prior knee injuries had significantly worse SF-
36 PCS than adults without prior knee injuries (52.4
[50.8, 54.1] vs. 54.9 [53.3, 56.4], p = 0.033). The com-
parison of IKDC and SF-36 scores between BL
closed adolescents, BL open adolescents, and adults
showed no significant differences between the groups
(P ≥ 0.145).
Growth plate status
At BL, 13 of the 18 adolescents (72%) had open tibial
and femoral growth plates, and were classified as BL
open adolescents for all analyses, and two boys and three
girls had closed growth plates, and were classified as BL
closed adolescents for all analyses. At FU, all adoles-
cents, except for one male, had closed growth plates.
Biomarkers
BL and FU biomarker values are shown in Table 2. At
both BL and FU, C2C-HUSA was greater in BL open ad-
olescents than in adults (p < 0.001). At BL, C2C-HUSA
was also greater in BL closed adolescents than in adults
(p = 0.007) but not at FU (p = 0.112). At both BL and
FU, CTX-II was greater in BL open adolescents than in
adults (p < 0.001). CTX-II was also greater in BL closed
adolescents than in adults at BL (p = 0.030) and FU (p =
0.034). Longitudinal changes in biomarkers are shown in
Table 3 and Fig. 1. BL open adolescents showed de-
creases in CPII (p = 0.028), C2C-HUSA (p = 0.012), and
CTX-II (p = 0.002). BL closed adolescents showed no
changes in biomarker levels from BL to FU (p ≥ 0.080).
Adults exhibited increases in CILP-2 (p = 0.021) and
C2C-HUSA (p = 0.033) from BL to FU. There were no
significant differences found in biomarker levels at BL or
FU between adults with and without prior knee injuries
(p ≤ 0.206).
Correlations between patient-rated outcomes and lon-
gitudinal biomarker changes
Results of correlation analyses are shown in Tables 4
and 5. In adolescents, BL IKDC scores were found to be
significantly and strongly correlated with CPII longitu-
dinal changes (r = −0.662, p = 0.037; Fig. 2). In adults, BL
SF-36 PCS were found to be significantly and moder-
ately correlated with COMP longitudinal changes (r =
−0.519, p = 0.027; Fig. 3).
Table 2 Biomarker Values a
BL Open Adolescents BL Closed Adolescents Adults P-value
CILP-2 [ng/ml] BL 0.56 (−0.059, 1.2) 0.98 (0.60, 1.4) 1.4 (0.90, 2.0) 0.13
FU 2.2 (1.4, 3.1) 3.0 (1.3, 4.6) 2.6 (2.0, 3.2) 0.775
COMP [U/l] BL 15.2 (11.8, 18.5) 11.5 (3.7, 19.3) 12.8 (10.8, 14.8) 0.406
FU 15.0 (13.1, 16.8) 12.1 (6.7, 17.6) 13.4 (11.8, 15.0) 0.537
sC2C [ng/ml] BL 167.9 (108.6, 227.1) 137.5 (18.6, 256.4) 120.5 (90.3, 150.7) 0.177
FU 123.3 (105.8, 140.7) 113.4 (70.2, 156.6) 159.6 (120.0, 199.3) 0.241
CPII [ng/ml] BL 310.4 (212.8, 407.9) 177.2 (−5.1, 359.5) 199.3 (139.7, 258.9) 0.164
FU 176.9 (139.7, 214.1) 161.8 (42.5, 281.0) 262.9 (144.7, 381.0) 0.862
C2C-HUSA [ng/mmol] BL 7.4 (2.3, 12.6) 3.6 (0.21, 7.0) 0.43 (0.33, 0.53) <0.001 *
0.007 **
FU 3.2 (1.9, 4.5) 1.3 (0.53, 2.0) 0.54 (0.39, 0.69) <0.001 *
0.112 **
CTX-II [ng/mmol] BL 10,675.6 (6038.9, 15,312.3) 3710.8 (259.7, 7161.9) 255.4 (177.2, 333.7) <0.001 *
0.030 **
FU 3312.2 (2255.6, 4368.9) 1499.8 (1181.6, 1818.1) 281.1 (203.5, 358.7) <0.001 *
0.034 **
* Statistically significant difference between BL open adolescents and adults
** Statistically significant difference between BL closed adolescents and adults
a BL baseline, FU follow-up, BL Open Adolescents adolescents with open growth plates at BL, BL Closed Adolescents adolescents with closed growth plates at BL. Data
provided as mean (95% confidence interval). P-values refer to differences between the three groups at BL or FU
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Discussion
The primary aims of this study were to compare bio-
markers of cartilage turnover in adolescent and adult
volleyball athletes over 2 years. Our main findings were
that in adolescents, regardless of growth plate status,
there were higher levels of C2C-HUSA and CTX-II than
in adults. Adolescents with BL open growth plates
showed decreases in CPII, C2C-HUSA, and CTX-II,
whereas adults showed increases in C2C-HUSA and
CILP-2, and adolescents with closed BL growth plates
showed no biomarkers changes from BL to FU. IKDC
scores were correlated with CPII changes in adolescents,
whereas SF-36 scores were correlated with COMP
changes in adults.
Fig. 1 Percentage longitudinal changes in biomarkers in baseline open adolescents, baseline closed adolescents and adults. Error bars represent
95% confidence intervals. *P < 0.05 for change from baseline to follow-up. a Percentage longitudinal changes in all biomarkers and ratios assessed,
with the exception of cartilage intermediate layer protein 2 (CILP-2). b Percentage longitudinal change in cartilage intermediate layer protein
2 (CILP-2)
Table 3 Biomarker Longitudinal Changes a
BL Open Adolescents P-value BL Closed Adolescents P-value Adults P-value
CILP-2 [ng/ml] 0.79 (−0.32, 1.9) 0.116 1.8 (−0.72, 4.4) 0.144 1.2 (0.23, 2.1) 0.021*
COMP [U/l] 1.3 (−1.4, 4.1) 0.917 0.13 (−8.5, 8.7) >0.999 0.44 (−1.4, 2.3) 0.948
sC2C [ng/ml] −54.3 (−131.4, 22.7) 0.116 −36.3 (−142.6, 70.1) 0.273 43.1 (−14.4, 100.7) 0.17
CPII [ng/ml] −128.8 (−231.4, −26.2) 0.028* −57.9 (−253.1, 137.2) 0.273 73.4 (−75.1, 221.8) 0.586
C2C-HUSA [ng/mmol] −7.8 (−17.8, 2.0) 0.012* −2.5 (−6.7, 1.6) 0.080 0.1079 (−0.0061, 0.22) 0.033*
CTX-II [ng/mmol] −11,051.3 (−18,920.3, −3182.2) 0.002* −2652.8 (−7578.2, 2272.7) 0.080 25.6 (−18.5, 69.9) 0.26
*Statistically significant difference (P < 0.05)
a BL baseline, BL Open Adolescents adolescents with open growth plates at BL, BL Closed Adolescents adolescents with closed growth plates at BL. Data provided as
mean (95% confidence interval)
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C2C-HUSA is an assay that recognizes a 45 mer
collagenase-generated cartilage derived peptide contain-
ing the C2C neoepitope. It has been found to increase
with the onset and progression of cartilage degeneration
in patients with early articular cartilage degeneration
and in those with knee OA (Cibere et al. 2009). A study
in knee OA patients found that C2C-HUSA levels were
correlated with more severe knee cartilage lesions, lower
Knee Injury and Osteoarthritis Outcome Scores
(KOOS), and worse functional abilities of the lower limb
(Tamm et al. 2014). The increase of C2C-HUSA we
found in adults is likely reflective of cartilage breakdown
in that cohort over 2 years, corroborating a previous
study in this cohort which found a decrease in their knee
cartilage thickness and subchondral bone plate area dur-
ing this time period (Eckstein et al. 2014). In contrast,
C2C-HUSA decreased in BL open adolescents likely due
to their ongoing growth, in which type II collagen cleav-
age by collagenases is very pronounced in the hyper-
trophic zone (Bernardo et al. 2011). Interestingly, both
adolescents with and without open growth plates at BL
had significantly higher levels of C2C-HUSA at BL than
adults, although this did not reach statistical significance
at FU for BL closed adolescents. This difference between
the age groups is possibly due to the higher volleyball
training intensity in the adolescents in comparison to
the adults, which may have led to a higher rate of imme-
diate cartilage degradation in the adolescents, and sug-
gests that C2C-HUSA may reflect more short-term,
immediate cartilage turnover stimulated by high joint
loading. This encourages further studies of C2C-HUSA
to determine whether it can predict risk of knee OA in
this high-risk population.
High levels of the articular cartilage degradative
marker CTX-II, the C-telopeptide of type II collagen,
have also previously been associated with greater risk
(Cibere et al. 2009) and severity (Fang et al. 2001, Jiao
et al. 2016) of radiographic OA, as well as with MRI-
detected knee cartilage defects in subjects with and
without radiographic OA (Ding et al. 2005). Elevated
CTX-II has also been found in the urine of growing
children, attributed to growth plate activity, and was
found to decrease with age in a study of healthy adults
between the ages of 20 and 55 years (Mouritzen et al.
2003). These findings could explain the significantly
higher levels of CTX-II in both groups of adolescents
than in adult volleyball players in our study at both BL
and FU and the decrease in CTX-II from BL to FU in
the BL open adolescents, reflecting the transition from
open to closed growth plates. However, our finding
that levels of CTX-II at FU were greater in both
groups of adolescents than in adults, when all adoles-
cents but one had closed growth plates, suggests that
CTX-II also reflects elevated cartilage turnover due to
the adolescents’ higher volleyball activity levels in
addition to growth. Similarly, a study by O’Kane at al.
in varsity college athletes found that CTX-II was sig-
nificantly higher in runners than in crew, swimmers,
or controls (O’Kane et al. 2006). They concluded that
the high levels of CTX-II in runners were caused by
the increased amount of cartilage remodeling or deg-
radation in that group due to joints stressed by high
amplitude loading of the lower skeleton (O’Kane et al.
2006). Volleyball players likely experience similar
amounts of mechanical loading as runners, as both are
high-impact sports with substantial loading of the
lower limbs. Thus, this study adds to previous findings
Table 5 Spearman’s Correlations Between Baseline Patient-Rated
Outcomes and Longitudinal Biomarker Changes in Adults a
IKDC SF-36 PCS SF-36 MCS
CILP r −0.099 −0.296 −0.148
P-value 0.695 0.233 0.559
COMP r 0.114 −.519 0.149
P-value 0.653 0.027* 0.556
sC2C r −0.319 0.406 0.163
P-value 0.197 0.095 0.518
CPII r −0.293 0.207 0.232
P-value 0.239 0.409 0.354
C2C-HUSA r 0.193 0.130 −0.136
P-value 0.428 0.596 0.578
CTX-II r −0.195 0.228 −0.395
P-value 0.425 0.348 0.094
a N = 18 for all correlation analyses due to one adult female missing a baseline
serum sample, except for C2C-HUSA
Table 4 Spearman’s Correlations Between Baseline Patient-Rated
Outcomes and Longitudinal Biomarker Changes in Adolescents a
IKDC SF-36 PCS
CILP r 0.307 −0.212
P-value 0.388 0.556
COMP r −0.587 0.127
P-value 0.074 0.726
sC2C r −0.498 −0.236
P-value 0.143 0.511
CPII r −0.662 −0.248
P-value 0.037* 0.489
C2C-HUSA r −0.027 0.248
P-value 0.940 0.489
CTX-II r −0.464 −0.018
P-value 0.176 0.960
*Statistically significant difference (P < 0.05)
a N = 10 for all correlation analyses due to one adolescent male and five
adolescent females missing baseline serum samples, and one adolescent male
missing a follow-up serum sample
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suggesting that CTX-II reflects mechanical loading-
induced cartilage turnover, making it a promising bio-
marker to assess pre-OA cartilage changes in an ath-
letic, high-risk population.
CILP-2 is homologous to CILP-1, cartilage inter-
mediate layer protein-1, which is expressed in the
intermediate zone of articular cartilage and has been
associated with cartilage degenerative diseases (Lor-
enzo et al. 1998). CILP-2 is more localized to the dee-
per intermediate zone of articular cartilage at maturity,
and its expression has been found to be downregulated
in mice with experimentally-induced degenerative OA
(Bernardo et al. 2011). One study also found CILP-2
to be decreased in adults with radiographic knee OA
Fig. 2 Adolescent collagen synthesis marker C-propeptide of type II procollagen (CPII) changes plotted against baseline International Knee
Documentation Committee scores. N = 10 due to seven adolescent females missing baseline serum samples and one adolescent male
missing a follow-up serum sample
Fig. 3 Adult cartilage oligomeric matrix protein (COMP) changes plotted against Short-Form 36 (SF36) Physical Component Scores. N = 18 due to
one adult female missing a baseline serum sample
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compared to healthy controls. These findings suggest
that CILP-2 is inversely associated with cartilage de-
generation. Moreover, CILP-2 was found to be re-
stricted to articular cartilage and the meniscus and
absent in growth plate cartilage, suggesting that it is
characteristic of the specialized composition of the
extracellular matrix synthesized by articular chondro-
cytes (Bernardo et al. 2011). Thus, the longitudinal in-
crease in CILP-2 seen in adults may reflect long-term
articular cartilage remodeling from biomechanical
stresses augmented by volleyball participation. The
lack of longitudinal differences in CILP-2 in the ado-
lescents suggests that there are other age-related fac-
tors that contribute to its changes over time. It is also
interesting that there were no significant differences in
BL or FU levels of CILP-2 found between adolescents,
either combined or stratified by BL growth plate sta-
tus, and adults, suggesting that levels of this biomarker
may fluctuate over time in response to remodeling of
articular cartilage. Since CILP-2 has scarcely been in-
vestigated in the literature, further studies are required
to assess how it reflects cartilage changes in athletic as
well as osteoarthritic populations.
COMP, cartilage oligomeric matrix protein, is a non-
collagenous protein which binds and stabilizes type II
collagen fibers and is found in synovium, ligamentous
tissue, tendon, meniscus, and particularly articular cartil-
age (Hoch et al. 2012). In adults, SF-36 PCS scores were
moderately correlated with COMP changes. We found
that adults with prior knee injuries had significantly
worse SF-36 PCS than those without prior knee injuries,
although there was no difference in COMP levels found
between these two groups. Previous studies have found
serum COMP to increase in runners after a marathon
(Neidhart et al. 2000, Kim et al. 2009), but another
found that increased COMP in college soccer players
over a season did not reach the calculated minimum de-
tectable change (Hoch et al. 2012). Kersting et al. found
that COMP levels did not significantly change after a 1-
h training session, but noted that the standard deviation
and range of COMP levels were notably increased post-
exercise, indicating that changes may have occurred, al-
beit in different directions (Kersting et al. 2005). The
COMP levels in our adult volleyball players also ranged
widely at each point, with ranges of 14.1 U/I and 12.4
U/I at BL and FU, respectively. This may be why we did
not find the COMP level to statistically significantly
change over time in the adults, although there were
enough changes to correlate with SF-36 PCS scores. This
suggests that adult volleyball athletes with worse overall
physical status, regardless of prior injury status, tended
to have increases in COMP over 2 years. Although the
causes for this are unclear, larger studies with longer
follow-up times are required to assess how COMP
reflects patient-rated outcomes and cartilage changes in
high-risk populations.
This study had several limitations. A number of sub-
jects were missing serum samples at either BL or FU,
which decreased our sample size. Many subjects also
had prior knee injuries; however, we aimed to assess
how biomarkers of cartilage turnover were affected over
time in active volleyball athletes, including those who
had recovered from prior knee injuries. We also com-
pared biomarker values and patient-rated outcomes be-
tween these subgroups in the adults. Patient-reported
outcomes were not collected at FU, so longitudinal
changes in this measure could not be assessed.
There were also strengths to this study. Our cohort
consisted of two highly uniform age groups with differ-
ent levels of volleyball participation for comparison. Bio-
markers were assessed from both serum and urine
samples, which provided a comprehensive assessment of
metabolic and pathophysiological cartilage changes.
Patient-rated outcomes in both a knee-specific and gen-
eral health score were used to assess subjective clinical
outcomes at BL, which provided a more holistic picture
of subjective clinical status. This is also the first study to
assess long-term changes in biomarkers of cartilage
turnover in adolescent and adult volleyball athletes.
Conclusions
In conclusion, we found that the assessment of different
biomarker levels and their changes over time is feasible
in adolescent volleyball athletes with both open and
closed growth plates, even though they still grow, and
adult volleyball athletes. Specifically, adolescent volley-
ball athletes with both open and closed growth plates
had higher levels of the type II collagen degradative
biomarkers C2C-HUSA and CTX-II at BL than adult
volleyball athletes. Further, we found that CPII, C2C-
HUSA, and CTX-II decreased in BL open adolescents,
and that C2C-HUSA and CILP-2 increased in adult vol-
leyball athletes over 2 years. These findings suggest that
these biomarkers reflect differences in cartilage re-
sponses to high-impact joint loading in athletes of differ-
ent ages and stages of development. The associations
between patient-rated outcomes with CPII and COMP
changes suggest that these biomarkers may reflect pa-
tients’ subjective clinical status. Future studies are re-
quired to assess how these biomarkers relate to the risk
of future development of OA in athletes.
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